Cytokines and inflammatory pathways in the pathogenesis of multiple organ failure following abdominal aortic aneurysm repair

European Journal of Vascular and Endovascular Surgery

Volumn 22, Issue 6, 2001, Pages 485-495

  Bown, M J ^a   Nicholson, M L ^a   Bell, P R F ^a   Sayers, R D ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Abdominal; Aortic aneurysm; Critical care; Cytokines; Multiple organ failure

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR;

ABDOMINAL AORTA ANEURYSM; ANEURYSM SURGERY; AORTA CLAMPING; CARDIOVASCULAR SYSTEM; CAUSE OF DEATH; CIRCULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INJURY; INTESTINE ISCHEMIA; KIDNEY DISEASE; MEDIATOR RELEASE; MULTIPLE ORGAN FAILURE; MUSCULOSKELETAL SYSTEM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; RESPIRATORY SYSTEM; REVIEW; SEPSIS; TREATMENT OUTCOME;

EID: 0035662979     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2001.1522     Document Type: Review

References (130)

1. Surgical management of 671 abdominal aortic aneurysms: A 13-year review from a single centre
2. Operative mortality rates for intact and ruptured abdominal aortic aneurysms in Michigan: An eleven year statewide experience
3. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
4. Sepsis/SIRS, physiological classification, severity stratification, relation to cytokine elaboration and outcome prediction in post-trauma critical illness
5. Cytokine patterns after major vascular surgery, haemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure
6. Cytokine and fibrinogen response in patients undergoing open abdominal aortic aneurysm surgery
7. Transabdominal versus retroperitoneal incision for abdominal aortic surgery: Report of a prospective randomised trial
8. Comparative analysis of retroperitoneal and transperitoneal aortic replacement for aneurysm
9. Immunological and physiological responses to aortic surgery: Effect of reperfusion on neutrophil and monocyte activation and pulmonary function
10. Reperfusion plasma contains a neutrophil activator
11. Sequential systems failure after rupture of abdominal aortic aneurysms
12. Death in two Canadian intensive care units: Institutional difference and changes over time
13. Outcome of pediatric patients with multiple organ system failure
14. Prognosis in acute organ-system failure
15. Multiple, progressive, or sequential systems failure. A syndrome of the 1970s
16. The influence of sepsis and multisystem and organ failure on mortality in the surgical intensive care unit
17. Multiple organ failure. Pathophysiology and potential future therapy
18. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit
19. An evaluation of outcome from intensive care in major medical centers
20. Factors related to outcome in intensive care: French multicenter study
21. Outcome from intensive care II. A 5-year study of 1308 patients: Short-term outcome
22. Microbial infection and the septic response in critical surgical illness. Sepsis, not infection, determines outcome
23. Multiple organ failure
24. Multiple-organ failure. Generalized autodestructive inflammation?
25. Characterisation of interleukin-1 and interleukin-6 production by hepatic endothelial cells and macrophages
26. Cytokine and virus-stimulated airway smooth muscle cells produce IL-1 and other IL-6 type cytokines
27. Induction of intracellular interleukin-1 beta signals via type II interleukin-1 receptor in human gingival fibroblasts
28. Cytokine function: A study in biological diversity
29. Cytokine production and adhesive protein expression by endothelial cells after contact with polyethylene terephthalate
30. Shock and tissue injury induced by recombinant human cachectin
31. Comparison of numerical and phenotypic leukocyte changes during constant hydrocortisone infusion in normal humans with those in thermally injured patients
32. Macrophage deactivation by Interleukin 10
33. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
34. Structural requirements for inducible shedding of the p55 tumour necrosis factor receptor
35. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction
36. Sir Isaac Newton, sepsis, SIRS and CARS
37. Pro-inflammatory mediator activity, endogenous antagonists and the systemic inflammatory response in intra-abdominal sepsis
38. High Circulating levels of Interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines
39. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients
40. Sepsis and serum cytokine concentrations
41. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity
42. Interleukin-10 is associated with the development of sepsis in trauma patients
43. Plasma cytokine levels correlate with survival in patients with the sepsis syndrome
44. Interleukin-10 production during septicaemia
45. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection
46. The inflammatory response and its consequence for the clincl outcome following aortic aneurysm repair
47. Prostaglandins, cyclo-oxygenase inhibitors, and thromboxane synthetase inhibitors in the pathogenesis of multiple systems organ failure
48. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: Relevance to ischaemic heart disease
49. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6
50. Adhesion receptors and cytokine profiles in controlled tourniquet ischaemia in the upper extremity
51. Cytokines and adhesion molecules in elective and accidental trauma-related ischaemia/reperfusion
52. Post-ischemic extremities exhibit immediate release of tumour necrosis factor
53. Interleukin-1 and thromboxane release after skeletal muscle ischaemia and reperfusion
54. Bacterial translocation in multiple organ failure: Cause or epiphenomenon still unproven
55. The role of the gastrointestinal tract in postinjury multiple organ failure
56. Nitric oxide in the gut
57. Interleukin-4 and interleukin-13 differentially regulate epithelial chloride secretion
58. Involvement of platelet activating factor (PAF) in endotoxin or ischaemia induced intestinal hyperpermeability in the rat
59. ATP depletion induces an increase in the assembly of a labile pool of polymerised actin in endothelial cells
60. The presence of hemorrhagic shock increases the rate of bacterial translocation in blunt abdominal trauma
61. Evidence for tumour necrosis factor-induced pulmonary microvascular injury after intestinal ischaemia-reperfusion injury
62. The potential etiological role of tumour necrosis factor in mediating multiple organ dysfunction in rats following intestinal ischaemia-reperfusion
63. Cytokine networking in lung inflammation
64. Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischaemia/reperfusion
65. IL-6 knock-out mice exhibit resistance to splanchnic artery occlusion shock
66. High levels of portal TNF-alpha during abdominal aortic surgery in man
67. Lower limb ischaemia-reperfusion injury alters gastro-intestinal structure and function
68. Intestinal permeability is increased after major vascular surgery
69. Endotoxaemia, the generation of the cytokines and their relationship to intramucosal acidosis of the sigmoid colon in elective abdominal aortic aneurysm repair
70. Intestinal manipulation during elective artic aneurysm surgery leads to portal endotoxaemia and mucosal barrier dysfunction
71. Outcome of acute renal failure following surgical repair of ruptured abdominal aortic aneurysms
72. The cytokine-adhesion molecule cascade in ischaemia/reperfusion injury of the rat kidney
73. Cytokine gene expression and eicosanoid production in renal reperfusion injury
74. Effects of cytokines on nitric oxide pathways in human vasculature
75. Clinical biology of nitric oxide
76. Cachectin/tumour necrosis factor induces lethal shock and stress hormone responses in the dog
77. Interleukin 1 Induces a Shock-like State in Rabbits
78. The effect of endotoxin on sympathetic responses in the rat isolated perfused mesenteric bed: Involvement of nitric oxide and cyclo-oxygenase products
79. Cytokines and growth factors in endothelial dysfunction
80. Pro- and anti-inflammatory cytokines: Interactions with vascular endothelium
81. Molecular mechanisms and therapeutic strategies related to nitric oxide
82. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and pro-inflammatory cytokines
83. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells
84. Cytokines and endothelial cell biology
85. Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells
86. Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells
87. Characterization of the adherence of human monocytes to cytokine-stimulated human macrovascular endothelial cells
88. Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: Endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1
89. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines
90. Cytokine induced VCAM-1 and ICAM-1 expression in different organs of the mouse
91. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells
92. Direct expression cloning of vascular cell adhesion molecule-1, a cytokine-induced endothelial protein that binds to lymphocytes
93. TGF-beta(1) down-regulates inflammatory cytokine-induced VCAM-1 expression in cultured human glomerular endothelial cells
94. Prognosis in acute organ-system failure
95. Lung cytokines and ARDS
96. Non-cardiogenic pulmonary oedema in vascular surgery
97. Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotactic activity and inflammatory cytokines
98. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions
99. Tumour necrosis factor-a induces glomerular damage in the rabbit
100. Differential cytokine regulation of complement proteins in human glomerular epithelial cells
101. Human glomerular epithelial cells sythesize and secrete the third component of complement
102. Cytokines, mesangial cell activation and glomerular injury
103. Left ventricular systolic and diastolic dysfunction after infusion of tumour necrosis factor-α in conscious dogs
104. Interleukin 2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock
105. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: Role of cytokine-inducible nitric oxide synthase in cardiac myocytes
106. Cytokines and cardiac contractile function
107. ++ current by interleukin-1β in cultured rat ventricular myocytes
108. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte
109. Hormones common to the neuro-endocrine and immune systems
110. Interleukin 1 and interleukin 2 enhance proopiomelanocortin gene expression in pituitary cells
111. Interleukin-6 and the acute phase response
112. Interleukin-6, the third mediator of acute phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1β and tumour necrosis factor α
113. Lung-liver interactions in sepsis and multiple organ failure syndrome
114. Systemic cytokine response after major surgery
115. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome
116. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
117. Amelioration of liver damage induced by ischaemia and reperfusion with FR167653; a newly synthesized cytokine suppressive anti-inflammatory drug
118. The effect of FR167653 on pulmonary ischaemia-reperfusion in rats
119. Ischemic pre-conditioning prevents endothelial injury and systemic neutrophil activation during ischaemia-reperfusion in humans in vivo
120. Extraperitoneal approach reduces neutrophil activation, systemic inflammatory response and organ dysfunction in aortic aneurysm surgery
121. Midline retroperitoneal versus midline transperitoneal approach for abdominal aortic aneurysm repair
122. Endovascular, transperitoneal, and retroperitoneal abdominal aortic aneurysm repair: Results and costs
123. Endovascular vs open abdominal aortic aneurysm repair: A comparison of cardiac morbidity and mortality
124. Mortality rates following Endovascular repair of abdominal aortic aneurysms
125. An investigation of polymorphism in the interleukin-10 gene promoter
126. A novel Nla III polymorphism in the human IL-6 promoter
127. Polymorphism of the 5′-flanking region of the human tumour necrosis factor (TNF)-alpha gene in Japanese
128. Effects of a polymorphism in the human tumour necrosis factor alpha promoter on transcriptional activation
129. -308 Tumour Necrosis Factor (TNF) Polymorphism Is Not Associated With Survival in Severe Sepsis and Is Unrelated to Lipopolysaccharide Inducibility of the Human TNF Promoter
130. Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and Mortality